Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic
By
- AMS
posted
Oct 01, 2020 07:22 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Clinical management of psoriasis patients during the COVID-19 pandemic
- AMS
Added Jun 22, 2020
Blog Entry
2020 global survey from ISAPS sees significant changes in aesthetic procedures during pandemic
- AMS
Added Feb 02, 2022
Blog Entry
Treatment of severe pemphigus vulgaris during COVID-19 pandemic
- AMS
Added Aug 05, 2020
Blog Entry
Recommendations on trichological treatments during COVID-19 pandemic
- AMS
Added Jun 26, 2020
Blog Entry
Rituximab: a safe therapeutic option during the COVID-19 pandemic?
- AMS
Added Jul 30, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic